ELIPULSE - Trademark Details
Status: 701 - Section 8-Accepted
Image for trademark with serial number 86072457
Serial Number
86072457
Registration Number
4581805
Word Mark
ELIPULSE
Status
701 - Section 8-Accepted
Status Date
2019-09-30
Filing Date
2013-09-23
Registration Number
4581805
Registration Date
2014-08-05
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2014-03-18
Attorney Name
Nakia Gray, Esq.
Law Office Assigned Location Code
L20
Employee Name
RINKER, ANTHONY MICHAE
Statements
Goods and Services
(Based on Use in Commerce) (Based on 44(e)) Herbal supplements for medicinal purposes, specifically coronary heart disease
Translation of Words in Mark
The wording "Elipulse" has no meaning in a foreign language.
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2013-09-30
Primary Code
005
First Use Anywhere Date
2014-05-13
First Use In Commerce Date
2014-05-14
Current Trademark Owners
Party Name
Elixir Canada Medicine Company Ltd
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Elixir Canada Medicine Company Ltd
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Elixir Canada Medicine Company Ltd
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Elixir Canada Medicine Company Ltd
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Nakia Gray, Esq.
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing DateApplication NumberCountryForeign Priority Claim In
CanadaFalse
Trademark Events
Event DateEvent Description
2013-09-26NEW APPLICATION ENTERED IN TRAM
2013-09-30NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2014-01-02ASSIGNED TO EXAMINER
2014-01-02NON-FINAL ACTION WRITTEN
2014-01-02NON-FINAL ACTION E-MAILED
2014-01-02NOTIFICATION OF NON-FINAL ACTION E-MAILED
2014-01-16TEAS RESPONSE TO OFFICE ACTION RECEIVED
2014-01-16CORRESPONDENCE RECEIVED IN LAW OFFICE
2014-01-17TEAS/EMAIL CORRESPONDENCE ENTERED
2014-01-22EXAMINERS AMENDMENT -WRITTEN
2014-01-22EXAMINERS AMENDMENT E-MAILED
2014-01-22NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2014-01-22EXAMINER'S AMENDMENT ENTERED
2014-01-22APPROVED FOR PUB - PRINCIPAL REGISTER
2014-02-10ASSIGNED TO LIE
2014-02-11LAW OFFICE PUBLICATION REVIEW COMPLETED
2014-02-26NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2014-03-18PUBLISHED FOR OPPOSITION
2014-03-18OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2014-05-13NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2014-05-14TEAS CHANGE OF CORRESPONDENCE RECEIVED
2014-05-14TEAS STATEMENT OF USE RECEIVED
2014-06-06CASE ASSIGNED TO INTENT TO USE PARALEGAL
2014-05-14USE AMENDMENT FILED
2014-06-10STATEMENT OF USE PROCESSING COMPLETE
2014-06-30ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2014-06-30LAW OFFICE REGISTRATION REVIEW COMPLETED
2014-07-01NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2014-08-05REGISTERED-PRINCIPAL REGISTER
2019-08-05COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
2019-09-13TEAS SECTION 8 RECEIVED
2019-09-30CASE ASSIGNED TO POST REGISTRATION PARALEGAL
2019-09-30REGISTERED - SEC. 8 (6-YR) ACCEPTED
2019-09-30NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED